20
Growth Score
pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
980231
Protega Pharmaceuticals develops abuse-deterrent pain management products, including oxycodone hydrochloride tablets.
- Stefan Aigner: CEO, Chairman and Founder
- Hafid Touam: CBO & Co-Founder
About the Company
Protega Pharmaceuticals focuses on responsible pain management through the development of novel abuse-deterrent products. The company specializes in creating pharmaceutical solutions that aim to mitigate the risks associated with opioid use. Protega Pharmaceuticals is known for its innovative approach in the healthcare industry, particularly in the
commercialization of oxycodone hydrochloride tablets.
